INJECTABLE INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA IN THE PRESENCE OF SILICONE OIL TAMPONADE.

Q3 Medicine Retinal Cases and Brief Reports Pub Date : 2026-01-01 DOI:10.1097/ICB.0000000000001670

Kishan G Patel, Jessica Flores, Ashkan M Abbey

{"title":"INJECTABLE INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA IN THE PRESENCE OF SILICONE OIL TAMPONADE.","authors":"Kishan G Patel, Jessica Flores, Ashkan M Abbey","doi":"10.1097/ICB.0000000000001670","DOIUrl":null,"url":null,"abstract":"Purpose: This report describes the use of the injectable intravitreal fluocinolone acetonide implant (FAI) 0.18 mg for chronic postoperative cystoid macular edema in an eye with a silicone oil-filled vitreous cavity.Methods: A retrospective chart review was performed including surgical, clinical, and imaging data.Results: The patient had multiple complicated vitreoretinal surgical procedures including long-term silicone oil tamponade. The eye developed chronic cystoid macular edema, which responded to intravitreal steroid therapies and subsequently received FAI for long-term control. The eye had no complications related to FAI.Conclusion: FAI is a long-acting steroid that may be beneficial in controlling chronic cystoid macular edema. It can be considered for use in eyes with silicone oil tamponade, but further studies are required to better understand the pharmacokinetics and utility of the FAI when injected into silicone oil-filled vitreous cavities.","PeriodicalId":53580,"journal":{"name":"Retinal Cases and Brief Reports","volume":" ","pages":"29-31"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retinal Cases and Brief Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICB.0000000000001670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: This report describes the use of the injectable intravitreal fluocinolone acetonide implant (FAI) 0.18 mg for chronic postoperative cystoid macular edema in an eye with a silicone oil-filled vitreous cavity.

Methods: A retrospective chart review was performed including surgical, clinical, and imaging data.

Results: The patient had multiple complicated vitreoretinal surgical procedures including long-term silicone oil tamponade. The eye developed chronic cystoid macular edema, which responded to intravitreal steroid therapies and subsequently received FAI for long-term control. The eye had no complications related to FAI.

Conclusion: FAI is a long-acting steroid that may be beneficial in controlling chronic cystoid macular edema. It can be considered for use in eyes with silicone oil tamponade, but further studies are required to better understand the pharmacokinetics and utility of the FAI when injected into silicone oil-filled vitreous cavities.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

有硅油填塞的慢性CME术后玻璃体腔内注射氟西诺酮。

目的：本报告描述了玻璃体内注射醋酸氟西诺酮0.18mg植入物（FAI）治疗硅油填充玻璃体腔眼术后慢性囊样黄斑水肿（CME）的应用。方法：回顾性回顾图表，包括手术、临床和影像学资料。结果：患者进行了多次复杂的玻璃体视网膜手术，包括长期硅油填塞。眼睛发展为慢性CME，对玻璃体内类固醇治疗有反应，随后接受FAI治疗以进行长期控制。眼睛没有与FAI相关的并发症。结论：FAI是一种长效类固醇，可能有助于控制慢性CME。它可以用于硅油填塞的眼睛，但需要进一步的研究来更好地了解FAI注入硅油填充的玻璃体腔时的药代动力学和效用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊